Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
About the GEMINI-1 Clinical Trial The GEMINI-1 clinical trial was a multi-center, randomized, double-blind, placebo-controlled Phase 3 clinical study (NCT06396429) conducted by Hengrui in China to evaluate the efficacy and safety of HRS9531 injection in adults (18 years of age) with obesity (BMI 28 kg/m 2 ) or overweight (BMI 24 kg/m 2 ) and at least one weight-related comorbidity without diabetes
Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al
That said, if you're paying out of pocket for medication, Ro offers cash-pay options that are often significantly lower than retail prices
The two treatments work through different mechanisms and complement each other
US$ 28.18
.png)
US$ 20.94
US$ 20.01
US$ 28.67
US$ 21.44
